Hsp90 is involved in the formation of P-bodies and stress granules

Biochem Biophys Res Commun. 2011 Apr 22;407(4):720-4. doi: 10.1016/j.bbrc.2011.03.088. Epub 2011 Mar 31.

Abstract

Previously, we found that treatment of cells with the Hsp90 inhibitor geldanamycin (GA) leads to a substantial reduction in the number of processing bodies (P-bodies), and also alters the size and subcellular localization of stress granules. These findings imply that the chaperone activity of Hsp90 is involved in the formation of P-bodies and stress granules. To verify these observations, we examined whether another Hsp90 inhibitor radicicol (RA) affected P-bodies and stress granules. Treatment with RA reduced the level of the Hsp90 client protein Argonaute 2 and the number of P-bodies. Although stress granules still assembled in RA-treated cells upon heat shock, they were smaller and more dispersed in the cytoplasm than those in untreated cells. Furthermore eIF4E and eIF4E-transporter were dissociated selectively from stress granules in RA-treated cells. These observations were comparable to those obtained upon treatment with GA in our previous work. Thus, we conclude that abrogation of the chaperone activity of Hsp90 affects P-body formation and the integrity of stress granules.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Argonaute Proteins
  • Cytoplasmic Granules / drug effects
  • Cytoplasmic Granules / metabolism*
  • Eukaryotic Initiation Factor-2 / antagonists & inhibitors
  • Eukaryotic Initiation Factor-2 / metabolism
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors*
  • HSP90 Heat-Shock Proteins / metabolism*
  • HeLa Cells
  • Humans
  • Macrolides / pharmacology*
  • Nucleocytoplasmic Transport Proteins / metabolism

Substances

  • AGO2 protein, human
  • Argonaute Proteins
  • EIF4ENIF1 protein, human
  • Eukaryotic Initiation Factor-2
  • HSP90 Heat-Shock Proteins
  • Macrolides
  • Nucleocytoplasmic Transport Proteins
  • monorden